Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study)

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1396-1402

  Razavian, Mona ^a,b   Heeley, Emma L ^a,c   Perkovic, Vlado ^a,c   Zoungas, Sophia ^a,d   Weekes, Andrew ^e   Patel, Anushka A ^a,c   Anderson, Craig S ^a,c,f   Chalmers, John P ^a,c   Cass, Alan ^a,c  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e Servier Laboratories (Australia) Pty Ltd   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

chronic kidney disease; evidence based practice; general practice, primary care; vascular risk

Indexed keywords

AGED; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EVIDENCE BASED PRACTICE; FEMALE; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; POPULATION RISK; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT;

AGED; AUSTRALIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; GENERAL PRACTICE; GLOMERULAR FILTRATION RATE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; PROGNOSIS; RISK MANAGEMENT;

EID: 84859373018     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr599     Document Type: Article

References (38)

1. K/DOQI Working Group. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (2 Suppl. 1): S1-S266
2. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003; 14 (7 Suppl. 2): S131-S138 (Pubitemid 36750508)
3. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047 (Pubitemid 350074801)
4. Perkovic V, Cass A, Patel AA et al. High prevalence of chronic kidney disease in Thailand. Kidney Int 2008; 73: 473-479 (Pubitemid 351192918)
5. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008; 51: 373-384 (Pubitemid 351273470)
6. Thomas MC, Weekes AJ, Broadley OJ et al. The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust 2006; 185: 140-144 (Pubitemid 44262796)
7. Collins AJ, Vassalotti JA, Wang C et al. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis 2009; 53 (3 Suppl. 3): S71-S77
8. Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 2006; 67: 224-228 (Pubitemid 44305403)
9. Ninomiya T, Perkovic V, Verdon C et al. Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis 2009; 53: 417-425
10. Perkovic V, Verdon C, Ninomiya T et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med 2008; 5: e207
11. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065 (Pubitemid 37413751)
12. WeinerDE, TighiouartH,AminMGet al.Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315 (Pubitemid 38526012)
13. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
14. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663 (Pubitemid 38392981)
15. Perkovic V, Ninomiya T, Arima H et al. Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. J Am Soc Nephrol 2007; 18: 2766-2772 (Pubitemid 47531204)
16. Knox SA, Harrison CM, Britt HC et al. Estimating prevalence of common chronicmorbidities in Australia. Med J Aust 2008; 189: 66-70
17. Heeley EL, Peiris DP, Patel AA et al. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Med J Aust 2010; 192: 254-259
18. National Heart Foundation of Australia. Hypertension Management Guide for Doctors. Australia: National Heart Foundation, 2004
19. National Vascular Disease Prevention Alliance. Guidelines for the Assessment of Absolute Cardiovascular Disease Risk. Australia: National Vascular Disease Prevention Alliance, 2009
20. National Heart Foundation of Australia, Cardiac Society of Australia and New Zealand. Reducing Risk in Heart Disease 2004. Australia: National Heart Foundation of Australia.2005.
21. Coresh J, Byrd-Holt D, Astor BC et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180-188 (Pubitemid 43073171)
22. White SL, Polkinghorne KR, Cass A et al. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust 2008; 188: 204-208
23. Anandarajah S, Tai T, de Lusignan S et al. The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records. Nephrol Dial Transplant 2005; 20: 2089-2096 (Pubitemid 41510082)
24. Akbari A, Swedko PJ, Clark HD et al. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med 2004; 164: 1788-1792 (Pubitemid 39215649)
25. Mathew TH. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005; 183: 138-141 (Pubitemid 41087045)
26. Herget-Rosenthal S, Quellmann T, Linden C et al. Management of advanced chronic kidney disease in primary care-current data from Germany. Int J Clin Pract 2006; 60: 941-948 (Pubitemid 44082285)
27. Lenz O, Mekala DP, Patel DV et al. Barriers to successful care for chronic kidney disease. BMC Nephrol 2005; 6: 1128.
28. Stevens PE, O'Donoghue DJ, de Lusignan S et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72: 92-99 (Pubitemid 47014451)
29. Ravera M, Noberasco G, Re M et al. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Nephrol Dial Transplant 2009; 24: 1528-1533
30. de Galan BE, Perkovic V, Ninomiya T et al. Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol 2009; 20: 883-892
31. Jafar TH, Stark PC, Schmid CH et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensinconverting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139: 244-252
32. Strippoli GF, Navaneethan SD, Johnson DW et al. Effects of statins in patients with chronic kidney disease:meta-analysis andmeta-regression of randomised controlled trials. BMJ 2008; 336: 645-651 (Pubitemid 351481234)
33. Douglas K, O'Malley PG, Jackson JL. Meta-analysis: the effect of statins on albuminuria. Ann Intern Med 2006; 145: 117-124 (Pubitemid 46780585)
34. Sandhu S, Wiebe N, Fried LF et al. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 2006; 17: 2006-2016 (Pubitemid 44036185)
35. Bailie GR, Eisele G, Liu L et al. Patterns of medication use in the RRICKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant 2005; 20: 1110-1115 (Pubitemid 40862099)
36. Mason NA, Bakus JL. Strategies for reducing polypharmacy and other medication-related problems in chronic kidney disease. Semin Dial 2010; 23: 55-61
37. Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192
38. Howard K, White S, Salkeld G et al. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis. Value Health 2010; 13: 196-208